Allied Market Research has recently introduced a report titled “Biomaterials (Bio Implants) Market - Opportunities and Forecasts, 2014 -2020”. The report offers an in-depth insight into key drivers and restraining factors, market challenges, key segmentation on the basis of materials, application across geographies along with the profile of key market players.
Biomaterials are natural materials which are artificially derived and have large medical applications for the purpose of organ transplantation and replacement of tissues. The report highlights how the market for medical devices which accounted $240 billion in 2013 point to huge growth prospects of the bio-implants market. Increasing count of aging population across the world is a key driver for biomaterial market driven by increased applications of biomaterial is increasingly being used in wound healing, surgery, dental implants, neurology and tissue engineering. As per an estimate by the Society for Biomaterials, over 5000 novel research article are published every year for newer and innovative wound care techniques and surgical devices.
The report takes into account the potential growth opportunities of the key segments, impact analysis of top impacting factors, Porter’s Five Forces Analysis along with identifying top investment pockets using the strategic tool such as GE9 cell matrix analysis. The report offers key developmental strategies adopted by key market players which would provide in-depth understanding of potential opportunities and market challenges faced by prominent companies. The analysis is expected to offer an unbiased assessment of industry value chain and factors that will create potential growth prospects for top companies.
This report considers the competitive analysis of key market players. Top companies have collaborated to consolidate their positions in biomaterial market. For instance, Wright Medical Group recently completes the acquisition of BioMimetic Therapeutics Inc. which will help Wright’s Extermities business to expand its product portfolio by taking advantage of BioMimetic's cutting-edge biologics platform.
The report is aimed to key audiences such as medical device manufacturing companies, pharmaceutical companies, R&D institutes and academic institutes and other interested stakeholders.
Report Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/89
